Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-22135488

RESUMO

BACKGROUND: Significant heterogeneity of clinical presentation and disease progression exists within chronic obstructive pulmonary disease (COPD). Although forced expiratory volume in 1 second (FEV(1)) inadequately describes this heterogeneity, a clear alternative has not emerged. This article discusses and refines the concept of phenotyping desaturators in COPD and shows a possible pattern which could be used as a framework for future research. RECENT FINDINGS: COPD is a complex condition with pulmonary and extrapulmonary manifestations. We suggest that COPD phenotypes should be associated with clinically meaningful outcomes. The innovation of COPD phenotyping is defined as COPD desaturators. Sleep-related hypoxemia and hypercapnia are well recognized in COPD and the development of systemic inflammation during sleep. These sleep-related changes predispose to nocturnal cardiac arrhythmias, pulmonary hypertension, and possibly death, particularly during acute exacerbations. CONCLUSION: A more focused definition makes possible a classification of patients into two distinct subgroups for both clinical and research purposes. Establishing a common language for future research will facilitate our understanding and management of such diseases. Even if different treatment strategies have different outcomes for these groups, we will have confirmation, or otherwise, of the clinical value of cluster analysis. This knowledge could lead to pharmacological treatment and other interventions directed to specific phenotypic groups.


Assuntos
Ritmo Circadiano , Análise por Conglomerados , Hipóxia/diagnóstico , Pulmão/fisiopatologia , Oxigênio/sangue , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Testes de Função Respiratória , Idoso , Biomarcadores/sangue , Interpretação Estatística de Dados , Feminino , Volume Expiratório Forçado , Humanos , Hipóxia/sangue , Hipóxia/etiologia , Hipóxia/fisiopatologia , Inflamação/sangue , Inflamação/diagnóstico , Inflamação/fisiopatologia , Masculino , Pessoa de Meia-Idade , Fenótipo , Valor Preditivo dos Testes , Prognóstico , Doença Pulmonar Obstrutiva Crônica/sangue , Doença Pulmonar Obstrutiva Crônica/classificação , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Sono , Síndromes da Apneia do Sono/sangue , Síndromes da Apneia do Sono/diagnóstico , Síndromes da Apneia do Sono/fisiopatologia
2.
Rays ; 29(4): 391-400, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15856552

RESUMO

Based on a review of the literature on resectable lung cancer, pulmonary risk factors before, during and after surgery are discussed. The role of preoperative evaluation in order to determine the patient ability to withstand radical resection is considered. Spirometric indexes as forced expired volume (FEV1) and diffusing lung carbon monoxide capacity (DLCO) should be measured first. If FEV1 and DLCO are > 60% of predicted, patients are at low risk for complications and can undergo pulmonary resection. However, if FEV1 and DLCO are <60% of predicted, further evaluation with a quantitative lung scan is required. If predicted postoperative values for FEV1 and DLCO are >40%, patients can undergo lung resection, otherwise exercise testing is necessary. If the latter shows maximal oxygen uptake (VO2max) of > 15ml/Kg, surgery can be performed; if VO2max is <15 ml/Kg, patients are inoperable.


Assuntos
Neoplasias Pulmonares/fisiopatologia , Neoplasias Pulmonares/cirurgia , Cuidados Pré-Operatórios , Teste de Esforço , Humanos , Seleção de Pacientes , Pneumonectomia , Complicações Pós-Operatórias/prevenção & controle , Valor Preditivo dos Testes , Testes de Função Respiratória , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA